Topic: sales

gskhq

GSK extracting standout sales from former Novartis vaccine biz

GlaxoSmithKline had no shortage of critics back in 2014 when it signed the deal to offload its oncology assets and take on Novartis’ vaccines business. But the company may be feeling vindicated with projections that this year, the ex-Novartis’ vaccines business is set to soar past Novartis' earlier projections.